ICG dye imaging during surgery to check tumor edges
Treatments studied
Part of Cancer clinical trials.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a benign or malignant bone or soft-tissue mass planned for surgery at this hospital during the study time period
- You must be able to consent to the study
- You should not be pregnant or breastfeeding
- You should not have had a severe allergic reaction (anaphylaxis) to IV contrast or iodine
- Your kidney function must be good enough that your doctor clears you to receive ICG
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
This trial uses a special dye called ICG that is injected during surgery to help the surgeon see the blood flow to your colon and lymph nodes. It may help make the surgery more precise and improve outcomes for colon cancer.
This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.
This study tests whether giving a special dye (ICG) before minimally invasive liver surgery helps surgeons see tumors more clearly compared to using ultrasound alone. It’s for people who are already scheduled for keyhole liver surgery.
Hear when a new Benign Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.